Marvel Biosciences Corp. (MRVL.V)
CAD 0.1
(0.0%)
CAD 0.1
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.06 CAD | 25.9% |
| 2022 | -0.08 CAD | 54.12% |
| 2021 | -0.17 CAD | -30.77% |
| 2020 | -0.13 CAD | -295.14% |
| 2019 | -0.03 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | -0.01 CAD | -30.51% |
| 2024 Q2 | -0.01 CAD | 54.62% |
| 2024 Q1 | -0.01 CAD | 50.57% |
| 2023 Q2 | -0.01 CAD | 21.33% |
| 2023 FY | - CAD | 25.9% |
| 2023 Q3 | -0.02 CAD | -205.08% |
| 2023 Q4 | -0.03 CAD | -46.11% |
| 2023 Q1 | -0.01 CAD | 52.23% |
| 2022 Q1 | -0.02 CAD | 84.3% |
| 2022 FY | - CAD | 54.12% |
| 2022 Q4 | -0.02 CAD | -30.83% |
| 2022 Q2 | -0.03 CAD | -108.92% |
| 2022 Q3 | -0.01 CAD | 63.41% |
| 2021 Q2 | -0.01 CAD | 54.05% |
| 2021 Q1 | -0.01 CAD | 0.0% |
| 2021 FY | - CAD | -30.77% |
| 2021 Q3 | -0.01 CAD | -152.94% |
| 2021 Q4 | -0.10 CAD | -675.19% |
| 2020 FY | - CAD | -295.14% |
| 2019 FY | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Arch Biopartners Inc. | -0.05 CAD | -8.443% |
| Covalon Technologies Ltd. | -0.18 CAD | 67.889% |
| Hemostemix Inc. | -0.03 CAD | -90.759% |
| Universal Ibogaine Inc. | -0.06 CAD | -2.301% |
| Kane Biotech Inc. | -0.04 CAD | -61.003% |
| MedMira Inc. | -0.00 CAD | -1421.053% |
| NervGen Pharma Corp. | -0.38 CAD | 84.789% |
| XORTX Therapeutics Inc. | -1.44 CAD | 95.986% |